✦ LIBER ✦

Clinical importance of cytogenetics in acute myeloid leukaemia

✍ Scribed by Krzysztof Mrózek; Kristiina Heinonen; Clara D. Bloomfield

Book ID: 119754985
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 277 KB
Volume: 14
Category: Article
ISSN: 1521-6926
DOI: 10.1053/beha.2000.0114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytogenetics in acute myeloid leukaemia

✍ H Walker; F.J Smith; D.R Betts 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 985 KB

The clinical significance of cytogenetic

The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

✍ David Grimwade 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 460 KB

CYTOGENETIC STUDIES IN ACUTE MYELOID LEU

CYTOGENETIC STUDIES IN ACUTE MYELOID LEUKAEMIA

✍ Jensen, Mogens Krogh 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 454 KB

Cytogenetic findings and clinical outcom

Cytogenetic findings and clinical outcomes of adult acute myeloid leukaemia patients

✍ F. Iffet Sahin; E. Kizilkilic; T. Bulakbasi; Z. Yilmaz; C. Boga; O. Ozalp; S. Ka 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 84 KB

Cytogenetics of chronic myeloid leukaemi

Cytogenetics of chronic myeloid leukaemia

✍ Andrew Chase; Brian J.P. Huntly; Nicholas C.P. Cross 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Relevance of clinical trials in acute my

Relevance of clinical trials in acute myeloid leukaemia

✍ Apostolia M. Tsimberidou; Elihu Estey 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract Patients with newly diagnosed acute myeloid leukaemia (AML) are increasingly being enrolled in clinical trials sponsored by pharmaceutical companies or the National Cancer Institute. These trials routinely exclude patients who are less likely to respond (LLTR), e.g. those with Zubrod pe